Parkinson'S Disease Mechanisms And Treatments
23 researchers across 6 institutions
Research in Parkinson's disease mechanisms and treatments explores the fundamental biological processes that lead to neurodegeneration, with a focus on identifying novel therapeutic strategies. Investigations include examining the role of protein aggregation, mitochondrial dysfunction, and neuroinflammation in disease progression. Methodologies range from molecular and cellular biology techniques in laboratory settings to the study of genetic and environmental risk factors. The field also encompasses the development and testing of pharmacological interventions, as well as non-pharmacological approaches such as exercise and rehabilitation.
This research holds particular relevance for Arkansas's aging population, as Parkinson's disease prevalence increases with age. Understanding disease mechanisms can inform public health initiatives aimed at supporting individuals and families affected by neurodegenerative conditions. Furthermore, insights gained may contribute to the development of new diagnostic tools and treatments, potentially fostering innovation within the state's healthcare and biotechnology sectors.
The study of Parkinson's disease mechanisms and treatments draws on expertise from neuroscience, pharmacology, and behavioral sciences. This work involves collaborations across multiple Arkansas institutions, integrating diverse perspectives to address complex challenges in neurological health.
Top Researchers
| Name | Institution | h-index | Citations | Career Stage | Badges |
|---|---|---|---|---|---|
| J. L. Mehta | UAMS | 45 | 6,170 | High Impact | |
| Rohit Dhall | UAMS | 28 | 3,561 | High Impact | |
| Ruby Charak | UAMS | 25 | 2,098 | ||
| Yasir Rahmatallah | UAMS | 18 | 1,612 | ||
| Tuhin Virmani | UAMS | 18 | 1,534 | ||
| Asya Ozkızılcık | University of Arkansas | 17 | 508 | ||
| Prashanth Reddy | UAMS | 16 | 1,092 | ||
| Roger H.S. Langston | UAMS | 15 | 823 | ||
| Mark Groves | UA Div. of Agriculture | 14 | 1,235 | ||
| Lakshmi Pillai | UAMS | 13 | 643 | ||
| Aliyah Glover | UAMS | 9 | 235 | ||
| John V. Rider | University of Arkansas | 8 | 235 | ||
| Laura L. Pitts | University of Central Arkansas | 8 | 213 | ||
| Jennifer Sue Kleiner | UAMS | 6 | 484 | ||
| Shannon Doerhoff | UAMS | 4 | 108 | ||
| Kellie Coleman | UAMS | 3 | 32 | ||
| A M Arefin Khaled | UA Little Rock | 2 | 70 | ||
| Chris Oholendt | UAMS | 1 | 9 | ||
| Holly B. Bennett | University of Arkansas | 1 | 9 | ||
| M Harris | UAMS | 1 | 19 |
Related Research Areas
Connected Research Areas
Topics that share active collaborators with Parkinson'S Disease Mechanisms And Treatments in Arkansas. Pairs are ranked by collaboration density relative to expected co-authorship under a random null. This describes existing connections, not investment recommendations.
Strategic Outlook
Global signals from OpenAlex for this research area: where the field is growing, how concentrated leadership is, and where Arkansas sits relative to the world's top-100 institutions. Descriptive only — surfaced as input to the conversation about where to place bets, not a recommendation. Signal confidence: LOW
Top US institutions in this area
- 1 Harvard University 2,405
- 2 National Institutes of Health 2,073
- 3 University of Pennsylvania 2,005
- 4 Johns Hopkins University 1,786
- 5 Mayo Clinic in Florida 1,652
Cross-Institution Connections
Researchers at different institutions with overlapping expertise in Parkinson'S Disease Mechanisms And Treatments.